Amit Singal
Liver Tumor Program and Chief of Hepatology · University of Texas Southwestern Medical Center
Credentials: · · · · · · ·
History
PresentHepatology Division · University of Texas Southwestern Medical Center
Research
Review · Nature Reviews Disease Primers · 2021 · 5,588 citations
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Review · Journal of Hepatology · 2022 · 3,643 citations
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Hepatology · 2023 · First of 16 authors · 1,671 citations
142 papers · 17 as a fellow
114 papers · 18 as a fellow
95 papers
89 papers
47 papers · 10 as a resident
42 papers
41 papers
30 papers
Grants
- 2025–2030
UT Southwestern Liver Cancer SPORE
National Cancer Institute · P50
Contact PI · $5M · Ut Southwestern Medical Center
- 2023–2029
Epigallocatechin Gallate for Prevention of Lethal Cirrhosis Complications
National Cancer Institute · R01
PI · $1.8M · Ut Southwestern Medical Center
- 2023–2028
Precision Risk Stratification and Screening for HCC Among Patients with Indeterminate Liver Nodules
National Cancer Institute · U01
Contact PI · $3.9M · Ut Southwestern Medical Center
- 2022–2027
Clinical Validation Center for Hepatocellular Carcinoma
National Cancer Institute · U01
Contact PI · $4.7M · Ut Southwestern Medical Center
Clinical trials
- 2026–2030
Erlotinib for Hepatocellular Carcinoma Chemoprevention
Principal investigator · Not yet recruiting · Phase 2
University of Texas Southwestern Medical Center
- 2023–2034
National Liver Cancer Screening Trial
Principal investigator · Recruiting · Phase 4
University of Texas Southwestern Medical Center
- 2019–2027
Principal investigator · Active not recruiting
Glycotest, Inc.
- 2018–2021
Principal investigator · Completed
University of Texas Southwestern Medical Center